NCT01415895View on ClinicalTrials.gov

Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Back PainLower Back PainCervical Pain
Interventions
DRUG

Naltrexone and Clonidine Combination

subjects will receive 1 study drug capsule by mouth twice daily for 3 weeks, followed by 1 capsule in the morning for 3 days.

DRUG

placebo

subjects will receive 1 placebo capsule by mouth twice daily for 3 weeks, followed by 1 capsule in the morning for 3 days.

Trial Locations (1)

33181

Annette C. Toledano MD, North Miami

All Listed Sponsors
lead

Annette C. Toledano MD

INDUSTRY

NCT01415895 - Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain | Biotech Hunter | Biotech Hunter